EUDA Health Holdings Limited

NASDAQ:EUDA

Medical - Care Facilities

Healthcare
$17.70 +14.19%

+$2.20 today

Market cap
$53.00M
Beta
0.59
P/E (TTM)
-7.9
EPS (TTM)
-$1.79
52W Low $5.26High $71.20

Volume 0.04M

Average 0.02M

EUDA Income Tax Expense

Income taxes recognized for the period, including current and deferred tax.

EUDA Health Holdings LimitedNASDAQ: EUDA

Income Tax Expense · Q2 FY2026 · quarter ended Jun 2026

Income tax expense grows, but more slowly than its trailing trend

Q2 FY2026 income tax expense of $27.73K rose 1197.8% year over year, behind the +1470.3% change in trailing-twelve-month income tax expense. Sequentially, it rose 0.0% from the prior quarter.

Context

  • Income tax expense amounted to 0.6% of revenue in FY2025, up 0.5 pp from a year earlier.
  • Income tax expense increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +1197.8% toward the trailing-twelve-month pace of +1470.3%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
$27.73K+0.0% QoQ
Last fiscal yearDec 2025
$41.94K+1057.6% YoY
LTMJun 2026
$120.51K+1470.3% YoY
Income Tax Expense past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+1197.8%——
1 year+1057.6%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Income Tax Expense history

USD · from the income statement

Latest · FY2025
41.94K USD
Year-over-year change
+1057.6%
4-year CAGR
-2.5%

Income Tax Expense vs competitors

How EUDA compares with its peers on the latest reported figures

  • Peers report in different currencies, so income tax expense is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +1470.3% is the highest of 3, against a peer median of -60.2%.
  • Income tax expense amounts to 1.0% of revenue for EUDA, versus a peer median of 0.0%.
EUDA Competitors
Income Tax Expense for EUDA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
FONRFONAR CorporationLTM Mar 2026$2.5M USD-24.4%-17.5%2.4%
EUDAEUDA Health Holdings LimitedLTM Jun 2026$120.51K USD+1470.3%—1.0%
AMWLAmerican Well CorporationLTM Mar 2026$83K USD-95.9%+89.3%0.0%
DTILPrecision BioSciences, Inc.LTM Mar 2026$0 USD——0.0%
HYPRHyperfine, Inc.LTM Mar 2026$0 USD——0.0%
ZTEKZentek Ltd.LTM Mar 2026CA$0 CAD——0.0%
GUTSFractyl Health, Inc. Common StockLTM Mar 2026$0 USD———
ATYRaTyr Pharma, Inc.LTM Mar 2026$0 USD——0.0%
Peer median (excluding EUDA) —-60.2%+35.9%0.0%

Competitors are the stored peer set for EUDA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue4.56M3.76M3.71M4.01M6.82M
Cost of Revenue3.31M2.89M2.86M3.25M3.83M
Gross Profit1.25M870K842.08K762.16K2.99M
Gross Margin27.4%23.1%22.7%19.0%43.9%
Research & Development129.27K17.21K00249
Selling, General & Admin1.81M6.75M4.8M3.34M5.43M
Operating Expenses1.81M13.09M4.8M18.1M5.43M
Depreciation & Amortization264.1K172.02K119.35K173.22K406.48K
EBITDA1.34M(24.64M)(8.29M)(17.42M)(2.09M)
EBITDA Margin29.4%-654.6%-223.7%-434.4%-30.7%
Operating Income(559.99K)(5.72M)(3.96M)(17.34M)(2.44M)
Operating Margin-12.3%-151.9%-106.9%-432.2%-35.8%
Interest Income1.92M0000
Interest Expense127.13K93.78K23.23K44.89K228.62K
Other Income / Expenses2.23M(19.21M)(4.47M)(307.38K)(285.26K)
Income Before Tax1.67M(24.93M)(8.43M)(17.64M)(2.73M)
Pre-Tax Margin36.6%-662.3%-227.6%-439.8%-40.0%
Income Tax Expense46.49K(20.79K)0(4.38K)41.94K
Net Income864.83K(24.88M)(10.04M)(15.36M)(2.77M)
Net Margin19.0%-661.1%-270.9%-382.9%-40.7%
EPS (Basic)1.87(41.40)(8.80)(9.40)(1.49)
EPS (Diluted)1.87(41.40)(8.80)(9.40)(1.49)
Weighted Avg Shares462.67K601.48K1.15M1.62M1.86M
Weighted Avg Shares (Diluted)462.67K601.48K1.15M1.62M1.86M

EUDA Health Holdings Limited

NASDAQ:EUDA

Intrinsic Alpha fair value

Locked

Current Price

$17.70

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.